The Endpoints 11: Big dreams dominate among next-gen biotech players

Born during a boom but virtually shunned on Wall Street today, this group of upstarts is out to defy some tough odds in birthing a biotech. Here’s John Carroll’s top picks for the next-gen players of 2022 most likely to make their mark — or go down fighting for a landmark change. This marks Carroll’s 20th year selecting top private biotechs for special recognition. Join us at this special event in Boston to recognize this year’s group.

SCHEDULE
6:00 to 7:00pm — Networking, open bar & hors d'oeuvres

7:00 to 7:25pm — Fireside Chat 

• A one-on-one conversation featuring Nobel Prize laureate Phillip Sharp and Endpoints News Editor-in-chief John Carroll

7:30 to 8:15pm — Awards Presentation

• Join John Carroll & Catalent’s Alessandro Maselli as they award the teams behind the winning companies and learn what defines the Endpoints 11
  

Parking available for ticketed guests at no charge.